Experts
 Menu

R Paul Ross

Institution

Teagasc

Contact

Subjects

Microbiology

Details
Publications 333
As first author 2
As last author 129
Unique topics 1274
Collaborations 151
Patents 4
Sources 6
Are you R Paul Ross? Click here to provide feedback on your profile.
All
2015
2014
2013
2012
2011
2010
2009
2008
2007
Earlier
All
2015
2014
2013
2012
2011
2010
2009
2008
2007
Earlier

2015

A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius
2015

Antimicrobial antagonists against food pathogens; a bacteriocin perspective
2015

Bioengineering of the model lantibiotic nisin.
2015

Characterisation of the antibacterial properties of a bacterial derived peptidoglycan hydrolase (LysCs4), active against C. sakazakii and other Gram-negative food-related pathogens.
2015

Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice.
2015

Efficacies of Nisin A and Nisin V Semipurified Preparations Alone and in Combination with Plant Essential Oils for Controlling Listeria monocytogenes.
2015

Efficacy of nisin A and nisin V semi-purified preparations alone and in combination with plant essential oils to control Listeria monocytogenes
2015

Genome Sequence of the Heteropolysaccharide-Producing Strain Lactobacillus mucosae DPC 6426.
2015

Impact of environmental factors on bacteriocin promoter activity in gut-derived Lactobacillus salivarius.
2015

In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project's reference genome database.
2015

Lantibiotic Resistance.
2015

Nisin H is a new nisin variant produced by the gut-derived strain Streptococcus hyointestinalis DPC6484.
2015

Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers.
2015

Sugar-coated: exopolysaccharide producing lactic acid bacteria for food and human health applications.
2015

The Anti-Inflammatory Effect of Algae-Derived Lipid Extracts on Lipopolysaccharide (LPS)-Stimulated Human THP-1 Macrophages.
2015

The Effects of Freezing on Faecal Microbiota as Determined Using MiSeq Sequencing and Culture-Based Investigations
2015

The Gut Microbiota Composition in Dichorionic Triplet Sets Suggests a Role for Host Genetic Factors
2015

The composition of the gut microbiota throughout life, with an emphasis on early life.
2015

The neonatal gut harbours distinct bifidobacterial strains.
2015

The sactibiotic subclass of bacteriocins: an update.
2014

A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius.
2014

A degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and ß-lactam resistance genes in the gut microbiota
2014

Anaerobic sporeformers and their significance with respect to milk and dairy products.
2014

Atypical Listeria innocua strains possess an intact LIPI-3
2014

Bacterial neuroactive compounds produced by psychobiotics.
2014

Carbohydrate catabolic diversity of bifidobacteria and lactobacilli of human origin.
2014

Characterization of a bovine isolate Lactobacillus mucosae DPC 6426 which produces an exopolysaccharide composed predominantly of mannose residues.
2014

Complete Genome Sequence of vB_EcoM_112, a T-Even-Type Bacteriophage Specific for Escherichia coli O157:H7.
2014

Compositional dynamics of the human intestinal microbiota with aging: implications for health.
2014

Exercise and associated dietary extremes impact on gut microbial diversity.
2014

Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice.
2014

Exploiting gut bacteriophages for human health.
2014

Fermented beverages with health-promoting potential: Past and future perspectives
2014

Food and nutrient intake of Irish community-dwelling elderly subjects: who is at nutritional risk?
2014

Genome analysis of Cronobacter phage vB_CsaP_Ss1 reveals an endolysin with potential for biocontrol of Gram-negative bacterial pathogens.
2014

Genome analysis of the staphylococcal temperate phage DW2 and functional studies on the endolysin and tail hydrolase.
2014

Gut microbiota, the pharmabiotics they produce and host health.
2014

Heterologous expression of thuricin CD immunity genes in Listeria monocytogenes.
2014

Identification of aminoglycoside and β-lactam resistance genes from within an infant gut functional metagenomic library.
2014

Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice.
2014

Influence of carbon and nitrogen source on production of volatile fragrance and flavour metabolites by the yeast Kluyveromyces marxianus.
2014

Investigation of the Antimicrobial Activity of Bacillus licheniformis Strains Isolated from Retail Powdered Infant Milk Formulae.
2014

Lactobacillus ruminis strains cluster according to their mammalian gut source.
2014

Protein Quality and the Protein to Carbohydrate Ratio within a High Fat Diet Influences Energy Balance and the Gut Microbiota In C57BL/6J Mice
2014

Role of the gut in modulating lipoprotein metabolism.
2014

Streptozotocin-induced type-1-diabetes disease onset in Sprague-Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity.
2014

The Genome of the Predominant Equine Lactobacillus Species, Lactobacillus equi, Is Reflective of Its Lifestyle Adaptations to an Herbivorous Host.
2014

The effects of freezing on faecal microbiota as determined using MiSeq sequencing and culture-based investigations.
2014

The gut microbiota composition in dichorionic triplet sets suggests a role for host genetic factors.
2014

The potential for emerging therapeutic options for Clostridium difficile infection.
2013

A degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and β-lactam resistance genes in the gut microbiota.
2013

Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations.
2013

Bactofencin A, a New Type of Cationic Bacteriocin with Unusual Immunity
2013

Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract.
2013

Catabolic flexibility of mammalian-associated lactobacilli
2013

Characterization of plant-derived lactococci on the basis of their volatile compounds profile when grown in milk.
2013

Dietary glycaemic load associated with cognitive performance in elderly subjects.
2013

Draft Genome Sequence of Lactobacillus crispatus EM-LC1, an Isolate with Antimicrobial Activity Cultured from an Elderly Subject.
2013

Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection.
2013

High conjugated linoleic acid enriched ghee (clarified butter) increases the antioxidant and antiatherogenic potency in female Wistar rats
2013

Identification and characterization of an oleate hydratase-encoding gene from Bifidobacterium breve.
2013

In Silico Assigned Resistance Genes Confer Bifidobacterium with Partial Resistance to Aminoglycosides but Not to Β-Lactams
2013

In vivo activity of Nisin A and Nisin V against Listeria monocytogenes in mice
2013

Intensive Mutagenesis of the Nisin Hinge Leads to the Rational Design of Enhanced Derivatives
2013

Intestinal microbiota, diet and health.
2013

Microbial Composition of Human Appendices from Patients following Appendectomy.
2013

Phages of non-dairy lactococci: isolation and characterization of ΦL47, a phage infecting the grass isolate Lactococcus lactis ssp. cremoris DPC6860.
2013

Pro-Inflammatory Flagellin Proteins of Prevalent Motile Commensal Bacteria Are Variably Abundant in the Intestinal Microbiome of Elderly Humans
2013

Protein quality and the protein to carbohydrate ratio within a high fat diet influences energy balance and the gut microbiota in C57BL/6J mice.
2013

Saturation Mutagenesis of Lysine 12 Leads to the Identification of Derivatives of Nisin A with Enhanced Antimicrobial Activity
2013

Sequence-based analysis of the bacterial and fungal compositions of multiple kombucha (tea fungus) samples.
2013

Sequence-based analysis of the intestinal Microbiota of sows and their offspring fed genetically modified maize expressing a truncated form of Bacillus thuringiensis Cry1Ab protein (Bt Maize).
2013

Sequence-based analysis of the microbial composition of water kefir from multiple sources.
2013

Sequencing-Based Analysis of the Bacterial and Fungal Composition of Kefir Grains and Milks from Multiple Sources
2013

Strategies to improve the bacteriocin protection provided by lactic acid bacteria
2013

Targeting the Microbiota to Address Diet-Induced Obesity: A Time Dependent Challenge
2013

The Effect of Dietary Supplementation with Spent Cider Yeast on the Swine Distal Gut Microbiome
2013

The core faecal bacterial microbiome of Irish Thoroughbred racehorses.
2013

The individual-specific and diverse nature of the preterm infant microbiota.
2013

The microbial content of raw and pasteurized cow milk as determined by molecular approaches.
2013

The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
2013

The α-amylase and α-glucosidase inhibitory effects of Irish seaweed extracts.
2012

'Bac' to the future: bioengineering lantibiotics for designer purposes.
2012

A comparison of methods used to extract bacterial DNA from raw milk and raw milk cheese.
2012

Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy.
2012

Application of whey protein micro-bead coatings for enhanced strength and probiotic protection during fruit juice storage and gastric incubation.
2012

Assessing the contributions of the LiaS histidine kinase to the innate resistance of Listeria monocytogenes to nisin, cephalosporins, and disinfectants.
2012

Bacteriocins - a viable alternative to antibiotics?
2012

Bacteriophages phi MR299-2 and phi NH-4 can eliminate Pseudomonas aeruginosa in the murine Lung and on Cystic Fibrosis lung airway cells
2012

Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
2012

Bifidobacterium breve with α-Linolenic Acid and Linoleic Acid Alters Fatty Acid Metabolism in the Maternal Separation Model of Irritable Bowel Syndrome
2012

Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens
2012

Bioengineered nisin derivatives with enhanced activity in complex matrices.
2012

Carriage of Clostridium difficile in outpatients with irritable bowel syndrome.
2012

Characterization of Pro-Inflammatory Flagellin Proteins Produced by Lactobacillus ruminis and Related Motile Lactobacilli
2012

Characterization of the bovine innate immune response in milk somatic cells following intramammary infection with Streptococcus dysgalactiae subspecies dysgalactiae.
2012

Comparison of the principal proteins in bovine, caprine, buffalo, equine and camel milk
2012

Composition of the early intestinal microbiota: Knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps
2012

Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota.
2012

Cronobacter spp. in powdered infant formula.
2012

Effect of Lactobacillus salivarius Bacteriocin Abp118 on the Mouse and Pig Intestinal Microbiota
2012

Effect of feeding genetically modified Bt MON810 maize to ∼40-day-old pigs for 110 days on growth and health indicators.
2012

Effects of Feeding Bt MON810 Maize to Pigs for 110 Days on Peripheral Immune Response and Digestive Fate of the cry1Ab Gene and Truncated Bt Toxin
2012

Effects of Feeding Bt Maize to Sows during Gestation and Lactation on Maternal and Offspring Immunity and Fate of Transgenic Material
2012

Effects of feeding Bt MON810 maize to sows during first gestation and lactation on maternal and offspring health indicators.
2012

Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.
2012

Gut microbiota composition correlates with diet and health in the elderly.
2012

High-Throughput Sequencing Reveals the Incomplete, Short-Term Recovery of Infant Gut Microbiota following Parenteral Antibiotic Treatment with Ampicillin and Gentamicin
2012

High-throughput sequence-based analysis of the intestinal microbiota of weanling pigs fed genetically modified MON810 maize expressing Bacillus thuringiensis Cry1Ab (Bt maize) for 31 days.
2012

High-throughput sequencing for detection of subpopulations of bacteria not previously associated with artisanal cheeses.
2012

In vivo activity of nisin A and nisin V against Listeria monocytogenes in mice.
2012

Insights into Lantibiotic Immunity Provided by Bioengineering of LtnI.
2012

Isolation and characterization of bacteriocin-producing bacteria from the intestinal microbiota of elderly Irish subjects.
2012

Microbiota diversity and stability of the preterm neonatal ileum and colon of two infants.
2012

Movers and shakers: Influence of bacteriophages in shaping the mammalian gut microbiota.
2012

Prevalence and characterization of Clostridium perfringens from the faecal microbiota of elderly Irish subjects.
2012

Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid
2012

Production of the antimicrobial peptides Caseicin A and B by Bacillus isolates growing on sodium caseinate.
2012

Proteomic study of proteolysis during ripening of cheddar cheese made from milk over a lactation cycle
2012

Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.
2012

Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activity.
2012

Strategies to improve the bacteriocin protection provided by lactic acid bacteria.
2012

Subspecies diversity in bacteriocin production by intestinal Lactobacillus salivarius strains
2012

The Effect of Feeding Bt MON810 Maize to Pigs for 110 Days on Intestinal Microbiota
2012

The complex microbiota of raw milk.
2012

The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing.
2012

Transgenerational effects of feeding genetically modified maize to nulliparous sows and offspring on offspring growth and health.
2012

γ-Aminobutyric acid production by culturable bacteria from the human intestine.
2011

Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.
2011

BDNF expression in the hippocampus of maternally separated rats: does Bifidobacterium breve 6330 alter BDNF levels?
2011

Bacteriocin production: a probiotic trait?
2011

Bioactive peptides from muscle sources: meat and fish.
2011

Carbohydrate catabolic flexibility in the mammalian intestinal commensal Lactobacillus ruminis revealed by fermentation studies aligned to genome annotations
2011

Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota.
2011

Correlation of rRNA gene amplicon pyrosequencing and bacterial culture for microbial compositional analysis of faecal samples from elderly Irish subjects.
2011

Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota.
2011

Effects of short-term feeding of Bt MON810 maize on growth performance, organ morphology and function in pigs.
2011

Enhancing the stress responses of probiotics for a lifestyle from gut to product and back again
2011

Fate of Transgenic DNA from Orally Administered Bt MON810 Maize and Effects on Immune Response and Growth in Pigs
2011

Genetic response to bacteriophage infection in Lactococcus lactis reveals a four-strand approach involving induction of membrane stress proteins, D-alanylation of the cell wall, maintenance of proton motive force, and energy conservation.
2011

Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters
2011

Genome sequence of Bifidobacterium breve DPC 6330, a strain isolated from the human intestine.
2011

Genome sequences and comparative genomics of two Lactobacillus ruminis strains from the bovine and human intestinal tracts
2011

Homologues and bioengineered derivatives of LtnJ vary in ability to form D-alanine in the lantibiotic lacticin 3147.
2011

Host Specific Diversity in Lactobacillus johnsonii as Evidenced by a Major Chromosomal Inversion and Phage Resistance Mechanisms
2011

Impact of the broad-spectrum antimicrobial peptide, lacticin 3147, on Streptococcus mutans growing in a biofilm and in human saliva.
2011

Inhibitory activity of Lactobacillus plantarum LMG P-26358 against Listeria innocua when used as an adjunct starter in the manufacture of cheese
2011

Lantibiotic production by pathogenic microorganisms.
2011

Marine bioactives as functional food ingredients: potential to reduce the incidence of chronic diseases.
2011

Modification of the technical properties of Lactobacillus johnsonii NCC 533 by supplementing the growth medium with unsaturated fatty acids.
2011

Molecular approaches to analysing the microbial composition of raw milk and raw milk cheese.
2011

Myosin-cross-reactive antigen (MCRA) protein from Bifidobacterium breve is a FAD-dependent fatty acid hydratase which has a function in stress protection
2011

Novel conjugative plasmids from the natural isolate Lactococcus lactis subspecies cremoris DPC3758: a repository of genes for the potential improvement of dairy starters.
2011

Plasmids of raw milk cheese isolate Lactococcus lactis subsp. lactis biovar diacetylactis DPC3901 suggest a plant-based origin for the strain.
2011

Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid.
2011

Production of multiple bacteriocins from a single locus by gastrointestinal strains of Lactobacillus salivarius
2011

Real-time monitoring of luciferase-tagged Cronobacter sakazakii in reconstituted infant milk formula.
2011

Streptolysin S-like virulence factors: the continuing sagA.
2011

The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model.
2011

The effect of feeding Bt MON810 maize to pigs for 110 days on intestinal microbiota.
2011

The impact of nisin on sensitive and resistant mutants of Listeria monocytogenes in cottage cheese.
2011

The production of conjugated α-linolenic, γ-linolenic and stearidonic acids by strains of bifidobacteria and propionibacteria.
2011

The spiFEG locus in Streptococcus infantarius subsp. infantarius BAA-102 confers protection against nisin U.
2010

A study of the prevalence of methicillin-resistant Staphylococcus aureus in pigs and in personnel involved in the pig industry in Ireland.
2010

Assessment of Escherichia coli O157:H7-specific bacteriophages e11/2 and e4/1c in model broth and hide environments.
2010

Bacteriophages as biocontrol agents of food pathogens.
2010

Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z.
2010

Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions.
2010

Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases.
2010

Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon.
2010

Genome analysis of the Clostridium difficile phage PhiCD6356, a temperate phage of the Siphoviridae family.
2010

Glutamate decarboxylase-mediated nisin resistance in Listeria monocytogenes.
2010

Host specific diversity in Lactobacillus johnsonii as evidenced by a major chromosomal inversion and phage resistance mechanisms.
2010

In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria
2010

In vivo and ex vivo evaluations of bacteriophages e11/2 and e4/1c for use in the control of Escherichia coli O157:H7.
2010

Investigating the importance of charged residues in lantibiotics.
2010

Invited review: Lactobacillus helveticus--a thermophilic dairy starter related to gut bacteria.
2010

Lacticin 3147--biosynthesis, molecular analysis, immunity, bioengineering and applications.
2010

Metabolic activities and probiotic potential of bifidobacteria.
2010

Nutrient regulation of enteroendocrine cellular activity linked to cholecystokinin gene expression and secretion.
2010

Parenteral antibiotics reduce bifidobacteria colonization and diversity in neonates.
2010

Phage and their lysins as biocontrol agents for food safety applications.
2010

Real-time PCR assay to differentiate Listeriolysin S-positive and -negative strains of Listeria monocytogenes.
2010

Recombinant lactobacilli expressing linoleic acid isomerase can modulate the fatty acid composition of host adipose tissue in mice.
2010

Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V.
2010

Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P
2010

TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics.
2010

The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
2010

The dawning of a 'Golden era' in lantibiotic bioengineering.
2010

The health promoting properties of the conjugated isomers of α-linolenic acid.
2010

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.
2010

Use of viability staining in combination with flow cytometry for rapid viability assessment of Lactobacillus rhamnosus GG in complex protein matrices.
2009

A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species.
2009

Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1beta and IL-8 gene expression
2009

Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1β and IL-8 gene expression
2009

Association of beta-glucan endogenous production with increased stress tolerance of intestinal lactobacilli.
2009

Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics.
2009

Bacteriophage and their lysins for elimination of infectious bacteria.
2009

CRISPR analysis of bacteriophage-insensitive mutants (BIMs) of industrial Streptococcus thermophilus--implications for starter design.
2009

Comparative Analysis of Pyrosequencing and a Phylogenetic Microarray for Exploring Microbial Community Structures in the Human Distal Intestine
2009

Comparative genomics of lactic acid bacteria reveals a niche-specific gene set
2009

Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147.
2009

Crucial role for insertion sequence elements in Lactobacillus helveticus evolution as revealed by interstrain genomic comparison.
2009

Discovery of medically significant lantibiotics.
2009

Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis
2009

Efficacy of whey protein gel networks as potential viability-enhancing scaffolds for cell immobilization of Lactobacillus rhamnosus GG.
2009

Evaluation of an antimicrobial ingredient prepared from a Lactobacillus acidophilus casein fermentate against Enterobacter sakazakii.
2009

Evaluation of colostrum-derived human mammary-associated serum amyloid A3 (M-SAA3) protein and peptide derivatives for the prevention of enteric infection: in vitro and in murine models of intestinal disease.
2009

Exploitation of the diverse insertion sequence element content of dairy Lactobacillus helveticus starters as a rapid method to identify different strains.
2009

Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.
2009

Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147.
2009

Optimization of a reconstituted skim milk based medium for enhanced CLA production by bifidobacteria.
2009

Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.
2009

Reconstitution conditions for dried probiotic powders represent a critical step in determining cell viability.
2009

Role of gut microbiota in early infant development.
2009

The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
2008

A note on the evaluation of a beta-casein variant in bovine breeds by allele-specific PCR and relevance to β-casomorphin
2008

Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum.
2008

Characterization of enterocin- and salivaricin-producing lactic acid bacteria from the mammalian gastrointestinal tract.
2008

Comparative genomics of lactic acid bacteria reveals a niche-specific gene set.
2008

Inhibitory effect of conjugated alpha-linolenic acid from bifidobacteria of intestinal origin on SW480 cancer cells.
2008

Intramammary infusion of a live culture of Lactococcus lactis for treatment of bovine mastitis: comparison with antibiotic treatment in field trials
2008

Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from Irish waters.
2008

Lantibiotic immunity.
2008

Life under stress: the probiotic stress response and how it may be manipulated.
2008

Listeriolysin S, a Novel Peptide Haemolysin Associated with a Subset of Lineage I Listeria monocytogenes
2008

Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci.
2008

State transitions and physicochemical aspects of cryoprotection and stabilization in freeze-drying of Lactobacillus rhamnosus GG (LGG).
2008

The generation of nisin variants with enhanced activity against specific gram-positive pathogens.
2008

The presence of pMRC01 promotes greater cell permeability and autolysis in lactococcal starter cultures.
2007

A survey of the microbial and chemical composition of seven semi-ripened Provola dei Nebrodi Sicilian cheeses.
2007

A system for the random mutagenesis of the two-peptide lantibiotic lacticin 3147: analysis of mutants producing reduced antibacterial activities.
2007

Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains.
2007

Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.
2007

Cheese manufacture with milk with elevated conjugated linoleic acid levels caused by dietary manipulation.
2007

Controlling Listeria monocytogenes in Cottage cheese through heterologous production of enterocin A by Lactococcus lactis.
2007

Efficient method for generation of bacteriophage insensitive mutants of Streptococcus thermophilus yoghurt and mozzarella strains.
2007

Fate of the two-component lantibiotic lacticin 3147 in the gastrointestinal tract.
2007

Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125.
2007

Insertional mutagenesis to generate lantibiotic resistance in Lactococcus lactis.
2007

Presence of two Lactobacillus and Bifidobacterium probiotic strains in the neonatal ileum.
2007

Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part I: overview.
2007

Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part II: bioactive peptide functions.
2007

Rapid screening method for analyzing the conjugated linoleic acid production capabilities of bacterial cultures.
2007

Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity
2007

Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of Lactobacillus salivarius.
2007

Salmonella enterica phage-resistant mutant colonies display an unusual phenotype in the presence of phage Felix 01.
2007

Two-peptide lantibiotics: a medical perspective.
2006

A lacticin 3147 enriched food ingredient reduces Streptococcus mutans isolated from the human oral cavity in saliva.
2006

Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026.
2006

Characterization of plasmid pASV479 from Bifidobacterium pseudolongum subsp. globosum and its use for expression vector construction.
2006

Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
2006

Contribution of penicillin-binding protein homologs to antibiotic resistance, cell morphology, and virulence of Listeria monocytogenes EGDe.
2006

Enhanced survival of GroESL-overproducing Lactobacillus paracasei NFBC 338 under stressful conditions induced by drying.
2006

Evaluation of live-culture-producing lacticin 3147 as a treatment for the control of Listeria monocytogenes on the surface of smear-ripened cheese.
2006

Growth of probiotic lactobacilli in the presence of oleic acid enhances subsequent survival in gastric juice.
2006

Insertion sequence elements as mediators of strain diversity in Lactobacillus helveticus.
2006

Intestinal bifidobacteria that produce trans-9, trans-11 conjugated linoleic acid: a fatty acid with antiproliferative activity against human colon SW480 and HT-29 cancer cells.
2006

Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147.
2006

Plasmids of lactococci - genetic accessories or genetic necessities?
2006

Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity.
2006

Spontaneous resistance in Lactococcus lactis IL1403 to the lantibiotic lacticin 3147.
2006

The newly isolated lytic bacteriophages st104a and st104b are highly virulent against Salmonella enterica.
2006

Tolerance of Listeria monocytogenes to cell envelope-acting antimicrobial agents is dependent on SigB.
2006

pEOC01: a plasmid from Pediococcus acidilactici which encodes an identical streptomycin resistance (aadE) gene to that found in Campylobacter jejuni.
2005

Bacterial lantibiotics: strategies to improve therapeutic potential.
2005

Bacteriocins: developing innate immunity for food.
2005

Enumeration and identification of pediococci in powder-based products using selective media and rapid PFGE.
2005

Fermented functional foods based on probiotics and their biogenic metabolites.
2005

Genetic diversity in the lactose operons of Lactobacillus helveticus strains and its relationship to the role of these strains as commercial starter cultures.
2005

Genome analysis of the obligately lytic bacteriophage 4268 of Lactococcus lactis provides insight into its adaptable nature.
2005

Inhibition of bacteriophage K proliferation on Staphylococcus aureus in raw bovine milk.
2005

Insertional inactivation of determinants for Mg2+ and Co2+ transport as a tool for screening recombinant Lactococcus species clones.
2005

Intrinsic tolerance of Bifidobacterium species to heat and oxygen and survival following spray drying and storage.
2005

Isolation and characterization of two anti-staphylococcal bacteriophages specific for pathogenic Staphylococcus aureus associated with bovine infections.
2005

Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147.
2005

Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals.
2005

Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
2005

Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars.
2005

The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus.
2004

Bifidobacterium psychraerophilum sp. nov. and Aeriscardovia aeriphila gen. nov., sp. nov., isolated from a porcine caecum.
2004

Comparative survival of probiotic lactobacilli spray-dried in the presence of prebiotic substances.
2004

Controlled autolysis and enzyme release in a recombinant lactococcal strain expressing the metalloendopeptidase enterolysin A.
2004

Dry cow therapy with a non-antibiotic intramammary teat seal - a review
2004

Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7.
2004

Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content.
2004

Heterologous expression of lactose- and galactose-utilizing pathways from lactic acid bacteria in Corynebacterium glutamicum for production of lysine in whey.
2004

Improved stress tolerance of GroESL-overproducing Lactococcus lactis and probiotic Lactobacillus paracasei NFBC 338.
2004

Mining the microbiota of the neonatal gastrointestinal tract for conjugated linoleic acid-producing bifidobacteria.
2004

Processing effects on the nutritional advancement ofprobiotics and prebiotics
2004

Relative ability of orally administered Lactobacillus murinus to predominate and persist in the porcine gastrointestinal tract.
2004

Sequence analysis of the plasmid genome of the probiotic strain Lactobacillus paracasei NFBC338 which includes the plasmids pCD01 and pCD02.
2004

Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147
2004

Variable bacteriocin production in the commercial starter Lactococcus lactis DPC4275 is linked to the formation of the cointegrate plasmid pMRC02.
2003

A food-grade approach for functional analysis and modification of native plasmids in Lactococcus lactis.
2003

A lacticin 481-producing adjunct culture increases starter lysis while inhibiting nonstarter lactic acid bacteria proliferation during Cheddar cheese ripening.
2003

Generation of food-grade lactococcal starters which produce the lantibiotics lacticin 3147 and lacticin 481.
2003

Genomic diversity and relatedness of bifidobacteria isolated from a porcine cecum.
2003

Potential of the enterocin regulatory system to control expression of heterologous genes in Enterococcus.
2003

Production of enterolysin A by a raw milk enterococcal isolate exhibiting multiple virulence factors.
2003

The evaluation of a mupirocin-based selective medium for the enumeration of bifidobacteria from probiotic animal feed.
2002

Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species.
2002

Elevated enzyme release from lactococcal starter cultures on exposure to the lantibiotic lacticin 481, produced by Lactococcus lactis DPC5552.
2002

Genomic diversity within the genus Pediococcus as revealed by randomly amplified polymorphic DNA PCR and pulsed-field gel electrophoresis.
2002

Improved survival of Lactobacillus paracasei NFBC 338 in spray-dried powders containing gum acacia.
2002

Lactococcus lactis DPC5598, a plasmid-free derivative of a commercial starter, provides a valuable alternative host for culture improvement studies.
2002

Lantibiotics produced by lactic acid bacteria: structure, function and applications.
2002

Potential of bacteriocin-producing lactic acid bacteria for improvements in food safety and quality.
2002

Use of lacticin 481 to facilitate delivery of the bacteriophage resistance plasmid, pCBG104 to cheese starters.
2001

Direct in situ viability assessment of bacteria in probiotic dairy products using viability staining in conjunction with confocal scanning laser microscopy.
2001

Evaluation of a spray-dried lacticin 3147 powder for the control of Listeria monocytogenes and Bacillus cereus in a range of food systems.
2001

Heterologous expression of lacticin 3147 in Enterococcus faecalis: comparison of biological activity with cytolysin.
2001

Lantibiotics: structure, biosynthesis and mode of action.
2001

Market potential for probiotics.
2001

Naturally occurring lactococcal plasmid pAH90 links bacteriophage resistance and mobility functions to a food-grade selectable marker.
2001

Regulation of immunity to the two-component lantibiotic, lacticin 3147, by the transcriptional repressor LtnR.
2000

Combination of hydrostatic pressure and lacticin 3147 causes increased killing of Staphylococcus and Listeria.
2000

Comparative survival rates of human-derived probiotic Lactobacillus paracasei and L. salivarius strains during heat treatment and spray drying.
2000

Each peptide of the two-component lantibiotic lacticin 3147 requires a separate modification enzyme for activity.
2000

Efficient method for the detection of microbially-produced antibacterial substances from food systems.
2000

Identification and overexpression of ltnl, a novel gene which confers immunity to the two-component lantibiotic lacticin 3147.
2000

Novel type I restriction specificities through domain shuffling of HsdS subunits in Lactococcus lactis.
2000

Protection against Staphylococcus aureus mastitis in dairy cows using a bismuth-based teat seal containing the bacteriocin, lacticin 3147.
1999

Characterization and heterologous expression of the genes encoding enterocin a production, immunity, and regulation in Enterococcus faecium DPC1146.
1999

Developing applications for lactococcal bacteriocins.
1999

Evaluation of cheddar cheese as a food carrier for delivery of a probiotic strain to the gastrointestinal tract.
1999

Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147.
1999

In situ inversion of the conjugative transposon Tn916 in Enterococcus faecium DPC3675.
1999

Influence of a probiotic adjunct culture of Enterococcus faecium on the quality of cheddar cheese.
1999

Lacticin 3147 displays activity in buffer against gram-positive bacterial pathogens which appear insensitive in standard plate assays.
1999

The natural food grade inhibitor, lacticin 3147, reduced the incidence of mastitis after experimental challenge with Streptococcus dysgalactiae in nonlactating dairy cows.
1998

Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens.
1997

Evidence for regulation of the NADH peroxidase gene (npr) from Enterococcus faecalis by OxyR.

These are the 6 unique sources for R Paul Ross's 333 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.

Source #
Ireland -> National University of Ireland Galway 1
Ireland -> National University of Ireland Galway -> PubMed 1
Ireland -> Teagasc 242
Ireland -> Teagasc -> PubMed 191
Ireland -> University College Cork 102
Ireland -> University College Cork -> PubMed 82
29-Dec-1999

A SPRAY-DRIED BACTERIOCIN POWDER WITH ANTI-MICROBIAL ACTIVITY
+
29-Dec-1999

AN ANTIMICROBIAL EFFECTIVE AGAINST GRAM-POSITIVE PATHOGENS
+
09-Dec-1999

PROCESS FOR THE MANUFACTURE OF PROBIOTIC CHEESE
+
17-Oct-1996

BACTERIOCINS
+

  1. Further insights

    Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.

  2. Details

    Here is a quick breakdown of this expert's publication history

  3. Contact

    If this is the expert you have been looking for, simply click here to make contact.